{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:54:42Z","timestamp":1785743682954,"version":"3.56.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jdcr.2025.08.025","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:47:14Z","timestamp":1756946834000},"page":"86-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Immune checkpoint inhibitor-associated acquired reactive perforating collagenosis treated with dupilumab"],"prefix":"10.1016","volume":"65","author":[{"given":"Maya","family":"Gold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bogner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Kuraitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jdcr.2025.08.025_bib1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0190-9622(94)70065-6","article-title":"Acquired reactive perforating collagenosis. Report of six cases and review of the literature","volume":"30","author":"Faver","year":"1994","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2025.08.025_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.5826\/dpc.0804a11","article-title":"Dermoscopy features of acquired reactive perforating collagenosis: a case series","volume":"8","author":"Ormerod","year":"2018","journal-title":"Dermatol Pract Concept"},{"issue":"5","key":"10.1016\/j.jdcr.2025.08.025_bib3","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/jvc2.462","article-title":"Pembrolizumab-induced acquired perforating dermatosis","volume":"3","author":"Gu","year":"2024","journal-title":"JEADV Clin Pract"},{"issue":"3","key":"10.1016\/j.jdcr.2025.08.025_bib4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaad.2020.07.025","article-title":"Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus","volume":"84","author":"Elmariah","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2025.08.025_bib5","article-title":"Cutaneous adverse events of immune checkpoint inhibitors: a literature review","volume":"11","author":"Apalla","year":"2020","journal-title":"Dermatol Pract Concept"},{"issue":"12","key":"10.1016\/j.jdcr.2025.08.025_bib6","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/DAD.0000000000002026","article-title":"Acquired perforating dermatosis induced by PD-1 inhibitor: a case report","volume":"43","author":"Liu","year":"2021","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.jdcr.2025.08.025_bib7","first-page":"8","article-title":"Acquired reactive perforating collagenosis in skin of color","volume":"30","author":"McClure","year":"2024","journal-title":"Dermatol Online J"},{"issue":"14","key":"10.1016\/j.jdcr.2025.08.025_bib8","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1158\/1078-0432.CCR-22-3181","article-title":"Corticosteroids and cancer immunotherapy","volume":"29","author":"Goodman","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jdcr.2025.08.025_bib9","article-title":"Dupilumab improve acquired reactive perforating collagenosis characterized by type 2 inflammation","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.jdcr.2025.08.025_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/cts.13899","article-title":"Dupilumab: mechanism of action, clinical, and translational science","volume":"17","author":"McCann","year":"2024","journal-title":"Clin Transl Sci"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262500431X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S235251262500431X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T21:34:57Z","timestamp":1765316097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S235251262500431X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":10,"alternative-id":["S235251262500431X"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.08.025","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune checkpoint inhibitor-associated acquired reactive perforating collagenosis treated with dupilumab","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2025.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}